Obesity Management in Primary Care
18m
·
JAMA Clinical Reviews
·
Obesity affects approximately 42% of adults in the US. Multiple strategies are available to treat obesity, including behavior therapies, GLP-1 receptor agonists, and bariatric surgery. Therapies vary in effectiveness and risks. JAMA Deputy Editor Mary McGrae McDermott, MD, discusses evidence-based obesity treatment with Melanie Jay, MD, MS, New York University Grossman School of Medicine.
Related Content:
- Obesity Management in Adults
- As Semaglutide’s Popularity Soars, Rare but Serious Adverse Effects Are Emerging
- FDA Green-Lights Tirzepatide, Marketed as Zepbound, for Chronic Weight Management
The episode Obesity Management in Primary Care from the podcast JAMA Clinical Reviews has a duration of
18:15. It was first published
More episodes from JAMA Clinical Reviews
The Federal Trade Commission’s Role in the Oversight of Drug Companies
The Federal Trade Commission’s (FTC) oversight role in the pharmaceutical market is critical to the health of patients and the health care system. Aaron Kesselheim, MD, JD, MPH, and JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, discuss the FTC’s policies and legal actions related to alleged misconduct, consolidation, and anticompetitive behavior in the pharmaceutical market.
Related Content:
- Federal Trade Commission Actions on Prescription Drugs, 2000-2022
Financial Incentives for Weight Loss in Men With Obesity
Do text messages with or without financial incentives increase weight loss in men with obesity? Pat Hoddinott, MB, BS, PhD, of Stirling University talks with JAMA Deputy Editor Mary McGrae McDermott, MD, about the results of a randomized clinical trial that tested whether financial incentives combined with text messaging could help men with obesity lose weight.
Related Content:
- Text Messages With Financial Incentives for Men With Obesity
Service Animals in Health Care Settings
Over the last several years there has been a proliferation of assistance animals in health care, including service animals, therapy animals, and emotional support animals. Lisa I. Iezzoni, MD, MSc, of Harvard Medical School and the Health Policy Research Center at Massachusetts General Hospital, joins JAMA Senior Editor Karen E. Lasser, MD, MPH, to discuss service animals in health care settings.
Related Content:
- Service Animals in Health Care Settings
USPSTF Recommendation: Screening for Breast Cancer
Interview with Wanda K. Nicholson, MD, MPH, MBA, USPSTF Chair and coauthor of Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS.
Related Content:
- Collaborative Modeling to Compare Different Breast Cancer Screening Strategies
- Screening for Breast Cancer
- Screening for Breast Cancer
- Screening for Breast Cancer
- Toward More Equitable Breast Cancer Outcomes
Diagnosis and Treatment of Interstitial Lung Disease
Interstitial lung disease (ILD), characterized by inflammation and fibrosis of the lungs, is associated with progressive dyspnea and results in approximately 25 000 to 30 000 deaths in the US each year. Toby M. Maher, MD, MSc, PhD, of Keck Medicine of USC, discusses the diagnosis and management of ILD with JAMA Deputy Editor Mary McGrae McDermott, MD.
Related Content:
- Interstitial Lung Disease